Related Experiment Videos
Evaluation of the permissible mismatch concept
Abstract:
Maruya et al. described a method of separating one HLA-A+B+DR mismatched transplants into permissible and immunogenic categories (published in Clinical Transplants 1993). For the permissible subgroup, they observed an outcome similar to that of zero-A+B+DR mismatched transplants. The classification was based on the HLA type combination of donor and recipient. We evaluated this concept with the data of the Collaborative Transplant Study (CTS). We did not obtain significant differences between the outcome of immunogenic and permissible mismatched transplants. The pairwise p-values for the comparison of zero-mismatched with permissible mismatched transplants are significant for cadaver transplants. The indifferent results obtained in our analysis do not support the concept of permissible mismatches. A more restrictive definition of the permissible mismatches might be helpful. The current method appears to be of insufficient reliability due to the relatively small numbers of transplants in the individual subgroups used to identify permissible combinations.
Insights
The study found that the concept of "permissible mismatches" in HLA-A+B+DR mismatched transplants may not be reliable. Current classifications did not show significant outcome differences between permissible and immunogenic categories, questioning their clinical utility.
Area of Science:
- Immunogenetics
- Transplantation immunology
Background:
- The classification of Human Leukocyte Antigen (HLA) mismatches is crucial for transplant outcomes.
- Maruya et al. proposed a method to categorize single HLA-A+B+DR mismatches into permissible and immunogenic groups, suggesting similar outcomes for permissible mismatches as zero mismatches.
Purpose of the Study:
- To evaluate the validity of the proposed permissible mismatch classification using Collaborative Transplant Study (CTS) data.
- To determine if the distinction between permissible and immunogenic mismatches holds significant prognostic value in kidney transplantation.
Main Methods:
- Analysis of a large dataset from the Collaborative Transplant Study (CTS).
- Comparison of transplant outcomes between zero, permissible, and immunogenic HLA-A+B+DR mismatched groups.
- Statistical analysis to assess the significance of outcome differences between categories.
Main Results:
- No significant differences were observed in transplant outcomes between the immunogenic and permissible mismatched groups in the CTS data.
- While some pairwise comparisons showed significance for cadaveric transplants, the overall results did not support the concept.
- The reliability of the current classification method is questioned due to small subgroup sizes.
Conclusions:
- The findings do not support the concept of permissible mismatches as defined by Maruya et al.
- A more restrictive definition or alternative classification system for HLA mismatches may be necessary.
- The current method lacks sufficient reliability for clinical application in predicting transplant outcomes.